Lakewood-Amedex Biotherapeutics Inc. (LABT) stock
LABTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$0.21−0.00 (-2.23%)
Close on Nov 17, 2026Market cap $508.30KP/E –Yield –
Lakewood-Amedex Biotherapeutics total assets
Total assets on the balance sheet at the end of each period.
Lakewood-Amedex Biotherapeutics's total assets was $3.60M at Sep 30, 2026. For fiscal 2025 it was $481.60K.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $481.60K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.60M | – |
| Q2 FY2026 | Jun 30, 2026 | $4.96M | – |
| Q1 FY2026 | Mar 31, 2026 | $196.34K | – |
| Q4 FY2025 | Dec 31, 2025 | $481.60K | – |
See a number that looks wrong?